IRulya Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IRLA and other ETFs, options, and stocks.About IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells.
IRLA Key Statistics
Stock Snapshot
The current IRulya Therapeutics(IRLA) stock price is $29.75, with a market capitalization of 30.26M. The stock trades at a price-to-earnings (P/E) ratio of -0.25.
On 2026-10-12, IRulya Therapeutics(IRLA) stock moved within a range of $26.93 to $29.75. With shares now at $29.75, the stock is trading +10.5% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 50.11K, compared to an average daily volume of 39.58K.
Over the past 52 weeks, IRulya Therapeutics(IRLA) stock has traded between a high of $909.98 and a low of $4.99.
Over the past 52 weeks, IRulya Therapeutics(IRLA) stock has traded between a high of $909.98 and a low of $4.99.
IRLA News
...
An update from Quince Therapeutics ( (QNCX) ) is now available. On October 8–9, 2026, Quince Therapeutics implemented a broad relaunch as IRulya Therapeutics,...
Quince Therapeutics ( (QNCX) ) has issued an update. On October 6, 2026, Quince Therapeutics, Inc. held a special meeting of stockholders at which investors ap...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.